SPL 2.11% 9.3¢ starpharma holdings limited

Another positive DEP announcement. DEPs reduction in toxicity is...

  1. 587 Posts.
    lightbulb Created with Sketch. 79
    Another positive DEP announcement.

    DEPs reduction in toxicity is consistently positive along with further efficacy signs, even if only phase I it is consistent with other trials.

    a positive from the announcement is that they state recruitment is underway. I thought they would not be able to enrol new patients?

    SPL requires a lot of patience, but I’m confident DEP will be huge, commercially and for patients. When though...
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.